Current Scenario of Clinical Cancer Research in Latin America and the Caribbean
Current Oncology · 2023
DOI: 10.3390/curroncol30010050 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Gustavo Gössling und 8 weiteren Autor:innen. Beteiligte Einrichtung: Latin American Cooperative Oncology Group (LACOG), Porto Alegre 90619-900, RS, Brazil. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In Latin America and the Caribbean (LAC), progress has been made in some national and regional cancer control initiatives, which have proved useful in reducing diagnostic and treatment initiation delays. However, there are still significant gaps, including a lack of oncology clinical trials. In this article, we will introduce the current status of the region’s clinical research in cancer, with a special focus on academic cancer research groups and investigator-initiated research (IIR) initiatives. Investigators in LAC have strived to improve cancer research despite drawbacks and difficulties in funding, regulatory timelines, and a skilled workforce. Progress has been observed in the representation of this region in clinical trial development and conduct, as well as in scientific productivity. However, most oncology trials in the region have been sponsored by pharmaceutical companies, highlighting the need for increased funding from governments and private foundations. Improvements in obtaining and/or strengthening the LAC cancer research group’s financing will provide opportunities to address cancer therapies and management shortcomings specific to the region. Furthermore, by including this large, ethnic, and genetically diverse population in the world’s research agenda, one may bridge the gap in knowledge regarding the applicability of results of clinical trials now mainly conducted in populations from the Northern Hemisphere.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Latin American Cooperative Oncology Group (LACOG), Porto Alegre 90619-900, RS, Brazil.
- Breast Cancer Center Hospital Zambrano Hellion TecSalud-Tecnologico de Monterrey, Monterrey 66278, NL, Mexico.
- Grupo de Estudios Clínicos Oncológicos del Perú (GECO PERU), Lima 15038, Peru.
- Grupo Argentino de Investigación Clínica en Oncología (GAICO), Rosario S2124KBO, Argentina.
- Hospital BP-Beneficência Portuguesa de São Paulo, São Paulo 01323-001, SP, Brazil.
ORCID-Profile: Gustavo Gössling, Raul Sala, William N William
Zitieren
APA
Gössling, G., Rebelatto, T. F., Villarreal-Garza, C., Ferrigno, A. S., Bretel, D., Sala, R., Giacomazzi, J., William, W. N., & Werutsky, G. (2023). Current Scenario of Clinical Cancer Research in Latin America and the Caribbean. Current Oncology. https://doi.org/10.3390/curroncol30010050
Vancouver
Gössling G, Rebelatto TF, Villarreal-Garza C, Ferrigno AS, Bretel D, Sala R, et al. Current Scenario of Clinical Cancer Research in Latin America and the Caribbean. Current Oncology. 2023. doi:10.3390/curroncol30010050
BibTeX
@article{Gssling2023,
author = {Gössling, Gustavo and Rebelatto, Taiane F and Villarreal-Garza, Cynthia and Ferrigno, Ana S and Bretel, Denisse and Sala, Raul and Giacomazzi, Juliana and William, William N and Werutsky, Gustavo},
title = {Current Scenario of Clinical Cancer Research in Latin America and the Caribbean},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30010050}
}
EUVIMED